Discover how the breakthrough patented technology in Neola®, biomedical GASMAS, a unique method grounded in laser spectroscopy for observing the lung volume and the free oxygen gas concentration inside of the lung in real-time, aim to improve neonatal respiratory monitoring.
A detailed commentary on the review article, “Gas in Scattering Media Absorption Spectroscopy (GASMAS) as a potential tool in neonatal respiratory care,” published in Pediatric Research (2022), provides an insightful analysis of this cutting-edge technology. The commentary by Hemananda Kumar Muniraman, Judith Klein-Seetharaman, and Vineet Bhandari delves into the evolution of GASMAS and its significant clinical potential in neonatal respiratory monitoring, from delivery room stabilization to managing serious lung conditions that particuralry affects preterm born infants.
Learn how Neola®, the first groundbreaking medical device for non-invasive continuous monitoring of lungs of preterm born babies with instant detection of lung complications developed by Neola Medical, is set to enhance the standard of care in NICUs by diving into the fascinating journey of GASMAS development and its future in improving neonatal outcomes.
Read the commentary on the review article here: Article – Comment on GASMAS Review 2022
Read the full review article here: Article – GASMAS Review 2022